Halozyme Therapeutics shares owned by Calamos Advisors
Quarter-by-quarter ownership of Halozyme Therapeutics shares owned by Calamos Advisors
from 13F filings
Historical chart of Calamos Advisors investment in Halozyme Therapeutics
Tip: Access up to 7 years of quarterly data
All positions including Halozyme Therapeutics held by Calamos Advisors consolidated in one spreadsheet with up to 7 years of data
Download as csv
Download as Excel
Quarterly reported holdings in Halozyme Therapeutics by Calamos Advisors
| Quarter filed | Position value | Share count | Share price at filing |
|---|---|---|---|
| 2025-09-30 | $34M | 29M | 1.15 |
| 2025-06-30 | $29M | 29M | 1.00 |
| 2025-03-31 | $36M | 34M | 1.06 |
| 2024-12-31 | $28M | 29M | 0.96 |
| 2024-09-30 | $30M | 30M | 1.00 |
| 2024-06-30 | $4.4M | 4.6M | 0.96 |
| 2024-03-31 | $4.1M | 4.6M | 0.89 |
| 2023-12-31 | $4.0M | 4.6M | 0.86 |
| 2023-09-30 | $3.9M | 4.6M | 0.85 |
| 2023-06-30 | $5.9M | 7.1M | 0.83 |
| 2023-03-31 | $6.1M | 7.2M | 0.85 |
| 2022-12-31 | $5.8M | 5.9M | 0.97 |
| 2022-09-30 | $20M | 24M | 0.85 |
| 2022-06-30 | $39M | 44M | 0.88 |
| 2022-03-31 | $38M | 44M | 0.88 |